A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

AKGsOVIHAMS, a leading healthcare institution, has marked progress in treating ALS using integrative medicine. Known for combining conventional and alternative therapies, the institute has shown ...

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

Nevertheless, the new disappointment with DNL343 is another major disappointment to ALS patients, who have limited drug ...

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...

Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.

Clene (CLNN) and its subsidiary, Clene Nanomedicine announced new evidence from a cross-regimen, post hoc analysis of long-term survival in ...

Sarasota-Manatee partnership offers free hearing support; job fairs in Bradenton, Sarasota; Goodwill opens LWR outlet; arts ...

Patients increasingly complain that it is difficult to win approval from health insurance companies for certain types of treatment. Now, the ALS Association has introduced a new tool, the ALS ...